Barriers to Obtaining Waivers to Prescribe Buprenorphine for Opioid Addiction Treatment Among HIV Physicians

Overview

Journal J Gen Intern Med

Publisher Springer

Specialty General Medicine

Date 2007 Jul 11

PMID 17619934

Citations 56

Authors

Chinazo O Cunningham

Hillary V Kunins

Robert J Roose

Rashiah T Elam

Nancy L Sohler

Affiliations

Soon will be listed here.

Abstract

Background: Illicit drug use is common among HIV-infected individuals. Buprenorphine enables physicians to simultaneously treat HIV and opioid dependence, offering opportunities to improve health outcomes. Despite this, few physicians prescribe buprenorphine.

Objective: To examine barriers to obtaining waivers to prescribe buprenorphine.

Design: Cross-sectional survey study.

Participants: 375 physicians attending HIV educational conferences in six cities in 2006.

Approach: Anonymous questionnaires were distributed and analyzed to test whether confidence addressing drug problems and perceived barriers to prescribing buprenorphine were associated with having a buprenorphine waiver, using chi-square, t tests, and logistic regression.

Results: 25.1% of HIV physicians had waivers to prescribe buprenorphine. In bivariate analyses, physicians with waivers versus those without waivers were less likely to be male (51.1 vs 63.7%, p < .05), more likely to be in New York (51.1 vs 29.5%, p < .01), less likely to be infectious disease specialists (25.5 vs 41.6%, p < .05), and more likely to be general internists (43.6 vs 33.5%, p < .05). Adjusting for physician characteristics, confidence addressing drug problems (adjusted odds ratio [AOR] = 2.05, 95% confidence interval [95% CI] = 1.08-3.88) and concern about lack of access to addiction experts (AOR = 0.56, 95% CI = 0.32-0.97) were significantly associated with having a buprenorphine waiver.

Conclusions: Among HIV physicians attending educational conferences, confidence addressing drug problems was positively associated with having a buprenorphine waiver, and concern about lack of access to addiction experts was negatively associated with it. HIV physicians are uniquely positioned to provide opioid addiction treatment in the HIV primary care setting. Understanding and remediating barriers HIV physicians face may lead to new opportunities to improve outcomes for opioid-dependent HIV-infected patients.

Citing Articles

Physician Reluctance to Intervene in Addiction: A Systematic Review.

Campopiano von Klimo M, Nolan L, Corbin M, Farinelli L, Pytell J, Simon C JAMA Netw Open. 2024; 7(7):e2420837.

PMID: 39018077 PMC: 11255913. DOI: 10.1001/jamanetworkopen.2024.20837.

A survey of barriers and facilitators to the adoption of buprenorphine prescribing after implementation of a New Jersey-wide incentivized DATA-2000 waiver training program.

Nyaku A, Zerbo E, Chen C, Milano N, Johnston B, Chadwick R BMC Health Serv Res. 2024; 24(1):179.

PMID: 38331802 PMC: 10851589. DOI: 10.1186/s12913-024-10648-2.

Stigma towards opioid use disorder in primary care remain a barrier to integrating software-based measurement based care.

Dela Cruz A, Karns-Wright T, Kahalnik F, Walker R, Lanham H, Potter J BMC Psychiatry. 2023; 23(1):776.

PMID: 37875835 PMC: 10598938. DOI: 10.1186/s12888-023-05267-w.

Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomes.

Falade-Nwulia O, Agee T, Kelly S, Park J, Schwartz S, Hsu J Int J Drug Policy. 2023; 121:104191.

PMID: 37740989 PMC: 10844957. DOI: 10.1016/j.drugpo.2023.104191.

Machine learning assisted-nanomedicine using magnetic nanoparticles for central nervous system diseases.

Tomitaka A, Vashist A, Kolishetti N, Nair M Nanoscale Adv. 2023; 5(17):4354-4367.

PMID: 37638161 PMC: 10448356. DOI: 10.1039/d3na00180f.

References

Fleming M, Barry K, Davis A, Kropp S, Kahn R, Rivo M . Medical education about substance abuse: changes in curriculum and faculty between 1976 and 1992. Acad Med. 1994; 69(5):362-9. DOI: 10.1097/00001888-199405000-00009. View

Johnson T, Booth A, Johnson P . Physician beliefs about substance misuse and its treatment: findings from a U.S. survey of primary care practitioners. Subst Use Misuse. 2005; 40(8):1071-84. DOI: 10.1081/JA-200030800. View

Friedmann P, McCullough D, Saitz R . Screening and intervention for illicit drug abuse: a national survey of primary care physicians and psychiatrists. Arch Intern Med. 2001; 161(2):248-51. DOI: 10.1001/archinte.161.2.248. View

Arnsten J, Demas P, Grant R, Gourevitch M, Farzadegan H, Howard A . Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002; 17(5):377-81. PMC: 1495042. View

Lucas G, Cheever L, Chaisson R, Moore R . Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 2001; 27(3):251-9. DOI: 10.1097/00126334-200107010-00006. View

Fleming M, Manwell L, Kraus M, Isaacson J, Kahn R, Stauffacher E . Who teaches residents about the prevention and treatment of substance use disorders? A national survey. J Fam Pract. 1999; 48(9):725-9. View

Shapiro M, Morton S, McCaffrey D, Senterfitt J, Fleishman J, Perlman J . Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999; 281(24):2305-15. DOI: 10.1001/jama.281.24.2305. View

Chappel J, Veach T, KRUG R . The substance abuse attitude survey: an instrument for measuring attitudes. J Stud Alcohol. 1985; 46(1):48-52. DOI: 10.15288/jsa.1985.46.48. View

Lucas G, Gebo K, Chaisson R, Moore R . Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS. 2002; 16(5):767-74. DOI: 10.1097/00002030-200203290-00012. View

10.

Fleishman J, Gebo K, Reilly E, Conviser R, Mathews W, Korthuis P . Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002. Med Care. 2005; 43(9 Suppl):III40-52. DOI: 10.1097/01.mlr.0000175621.65005.c6. View

11.

Palepu A, Horton N, Tibbetts N, Meli S, Samet J . Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction. 2004; 99(3):361-8. DOI: 10.1111/j.1360-0443.2003.00670.x. View

12.

Samet J, Friedmann P, Saitz R . Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Arch Intern Med. 2001; 161(1):85-91. DOI: 10.1001/archinte.161.1.85. View

13.

Ford , Ryrie I . A comprehensive package of support to facilitate the treatment of problem drug users in primary care: an evaluation of the training component. Int J Drug Policy. 2000; 11(6):387-392. DOI: 10.1016/s0955-3959(00)00064-5. View

14.

West J, Kosten T, Wilk J, Svikis D, Triffleman E, Rae D . Challenges in increasing access to buprenorphine treatment for opiate addiction. Am J Addict. 2004; 13 Suppl 1:S8-16. DOI: 10.1080/10550490490440753. View

15.

Kissin W, McLeod C, Sonnefeld J, Stanton A . Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence. J Addict Dis. 2006; 25(4):91-103. DOI: 10.1300/J069v25n04_09. View

16.

Becker W, Fiellin D . Provider satisfaction with office-based treatment of opioid dependence: a systematic review. Subst Abus. 2006; 26(1):15-22. DOI: 10.1300/j465v26n01_02. View

17.

Saitz R, Friedmann P, Sullivan L, Winter M, Lloyd-Travaglini C, Moskowitz M . Professional satisfaction experienced when caring for substance-abusing patients: faculty and resident physician perspectives. J Gen Intern Med. 2002; 17(5):373-6. PMC: 1495049. View

18.

Park E, Wolfe T, Gokhale M, Winickoff J, Rigotti N . Perceived preparedness to provide preventive counseling: reports of graduating primary care residents at academic health centers. J Gen Intern Med. 2005; 20(5):386-91. PMC: 1490125. DOI: 10.1111/j.1525-1497.2005.0024.x. View

19.

Lucas G, Chaisson R, Moore R . Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999; 131(2):81-7. DOI: 10.7326/0003-4819-131-2-199907200-00002. View

20.

Gottlieb N, Mullen P, McAlister A . Patients' substance abuse and the primary care physician: patterns of practice. Addict Behav. 1987; 12(1):23-32. DOI: 10.1016/0306-4603(87)90005-0. View